EarningsQ3 2023 Earnings Report

ANI Pharmaceuticals (BSFA) Q3 2023 Earnings Report

0 Followers

DE:BSFA Q3 2023 EPS Results

Actual EPS€1.13

Consensus EPS€0.75

Beat/MissBeat by +€0.38

One Year Ago EPS€0.57

Actual Revenue€117.57M

Expected Revenue€99.82M

Beat/MissBeat by +€17.75M

YoY Revenue Growth+57.27%

QuarterQ3 2023

Date11/08/2023

TimeBefore Open

Conference CallWednesday, November 8, 2023

DE:BSFA Upcoming Earnings

ANI Pharmaceuticals's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

DE:BSFA Q3 2023 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	1.95 / -	1.819	―
Aug 07, 2026	2026 (Q2)	1.82 / 1.97	1.605	22.78% (+0.37)
May 08, 2026	2026 (Q1)	1.16 / 1.83	1.516	20.59% (+0.31)
Mar 03, 2026	2025 (Q4)	1.78 / 2.08	1.454	42.94% (+0.62)
Nov 10, 2025	2025 (Q3)	1.58 / 1.82	1.195	52.24% (+0.62)
Aug 08, 2025	2025 (Q2)	1.25 / 1.61	0.91	76.47% (+0.70)
May 09, 2025	2025 (Q1)	1.23 / 1.52	1.079	40.50% (+0.44)
Feb 28, 2025	2024 (Q4)	1.28 / 1.45	0.892	63.00% (+0.56)
Nov 08, 2024	2024 (Q3)	0.97 / 1.20	1.133	5.51% (+0.06)
Aug 06, 2024	2024 (Q2)	0.85 / 0.91	1.142	-20.31% (-0.23)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed